Xiaolong Liu

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 09, 2025
CD103+ T Cells Eliminate Damaged Alveolar Epithelial Type II Cells Under Oxidative Stress to Prevent Lung Tumorigenesis.

Yu Xu, Haorui Luo, Jiahao Wang

|Oct 27, 2022
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia.

Cheng-Long Hu, Bing-Yi Chen, Zijuan Li

|Sep 14, 2019
TGF-β signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity.

Xiang Sun, Yu Cui, Haiyun Feng

|Sep 26, 2018
Regulation of the terminal maturation of iNKT cells by mediator complex subunit 23.

Yu Xu, Yang Sun, Hao Shen

|Sep 16, 2018
Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells.

Xufeng Chen, Jingyao Zhao, Chan Gu

Pageof 2